The page is the record's research on the issuer — no analyst, no rating, no view. # ALX ONCOLOGY HOLDINGS INC (NASDAQ: ALXO) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is ALX ONCOLOGY HOLDINGS INC, listed on NASDAQ under ticker ALXO, with ISIN US00166B1052. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-DE exists. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 53 filings in the twelve months to 2026-11-08, on 31 filing days. The median gap between filing days is 7.0 days. The latest filing is dated 2026-10-16, is of type regulatory_filing, and sits 23 days before the record date. The exchange median gap is 6.0 days across 4359 issuers, and the sector median gap is 6.0 days across 526 issuers. The exchange median latency is 5.0 days, and the sector median latency is 4.0 days. The exchange median of 52 filings is below the issuer's 53 filings, and the sector median of 63.0 filings is above it. By type, the window holds 23 directors_dealings, 14 regulatory_filing, 6 results, 4 corporate_news, 3 director_change, 2 agm_egm and 1 prospectus filing. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found on the record. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001810182.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ALXO (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ALXO (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ALXO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp